ACSL5 and metabolic dysfunction-associated steatotic liver disease: Their data demonstrated that ACSL5 deacetylation by SIRT6 can protect against lipotoxicity and maintain FFA metabolism homeostasis in an NAFLD model by enhancing FAO.